Analytical Profiles of Drug Substances and Excipients, Vol. by Harry G. Brittain

By Harry G. Brittain

Even supposing the professional compendia outline a drug substance as to id, purity, energy, and caliber, they commonly don't supply different actual or chemical info, nor do they record tools of synthesis or pathways of actual or organic degradation and metabolism. Such details is scattered through the medical literature and the records of pharmaceutical laboratories. Analytical Profiles of Drug components and Excipients, brings the newest details jointly in a single source.•Represents an important contribution to the perform of pharmaceutical research• provides an outstanding review of actual, chemical, and biomedical houses of a few usually pharmaceuticals• every one quantity within the sequence incorporates a cumulative index

Show description

Read or Download Analytical Profiles of Drug Substances and Excipients, Vol. 29 PDF

Best pharmacy books

Optimization in Drug Discovery: In Vitro Methods

Completely revised and up-to-date, Optimization in Drug Discovery: In Vitro tools, moment variation provides a large spectrum of in vitro assays together with formula, plasma binding, absorption and permeability, cytochrome P450 (CYP) and UDP-glucuronosyltransferases (UGT) metabolism, CYP inhibition and induction, drug transporters, drug-drug interactions through overview of reactive metabolites, genotoxicity, and chemical and photo-mutagenicity assays.

Drug Calculations for Nurses : A step-by-step approach, Fourth Edition

The management of medicines in hospitals has turn into more and more advanced. It occasionally includes powerful medicines that could be deadly if administered incorrectly. the facility to accomplish drug calculations correctly is consequently paramount to avoid putting sufferers in danger. Drug Calculations for Nurses: A step by step technique teaches healthcare execs how you can practice drug calculations with self assurance and competence.

Good Pharma: The Public-Health Model of the Mario Negri Institute

Drawing on key recommendations in sociology and administration, this historical past describes a impressive institute that has increased clinical learn and labored out suggestions to the troubling practices of business pharmaceutical study. strong Pharma is the reply to Goldacre's undesirable Pharma: moral examine with out advertisement distortions.

Progress in medicinal chemistry

Growth in Medicinal Chemistry presents a evaluate of eclectic advancements in medicinal chemistry. This quantity contains chapters masking fresh advances in melanoma therapeutics,  fluorine in medicinal chemistry, a  viewpoint at the subsequent iteration of antibacterial brokers derived by means of manipulation of normal items, a  new period for Chagas disorder drug discovery?

Extra info for Analytical Profiles of Drug Substances and Excipients, Vol. 29

Sample text

References 59 60 . F. BELALAND ABDULLAHA. 3 Proprietary Names [1] Edathamil; EDTA; Havidote, Versene acid. 1 Empirical Formula, Molecular Weight, CAS Number [1-3] CloHI6N208. 71 Appearance [1] Edetic acid is obtained as crystals from water; Edetate sodium is a powder; Edetate disodium is composed of dihydrate crystals; Edetate trisodium is obtained as monohydrate crystals from water; Edetate calcium disodium is a tetrahydrate powder. All materials are white in color, and odorless. 5 F. BELALAND ABDULLAHA.

S. A. A. Pagliaro, J. Pharm. , 80, 674-676 (1991). 40. L. Ho, A. K. Sugden, Int. J. , 107, 199-203 (1994). 41. F. Tateo, L. Triangeli, E. Ciserchia, R. Nicoletti, and F. Berte, Boll. Chim. , 125, 404-409 (1986). 42. A. , Wiley-Interscience, New York, PP. 147-150 (1982). 43. S. Takahashi, E. Suzuki, and N. Nagashima, Bull. Chem. Soc. , 59, 1129-1132 (1986). 44. M. Maheswaran and S. Divakar, Indian J. , 30A, 30-34 (1991). 45. D. A. J. B. W. H. Perrin, Int. J. , 86, 263-265 (1992). 46. A. H. Schulpis, G.

Vieira, Analyst, 119, 2101-2104 (1994). 58. E. ), 133-137 (2000). 59. G. O. Sagidi, and A. Olcay, Acta Pharm. , 42, 1-5 (2000). 60. T. Hamano, Y. Mitsuhashi, N. Aoki, S. Yamamoto, S. Tsuji, Y. Ito, and Y. Oji, Analyst, 115, 435-438 (1990). 61. C. Guven and T. Ozol, Aeta Pharm. 66,28-30 (1984). 62. T. Ozol, Acta Pharm. Turcica, 266, 59-62 (1984). 63. E. Hassan, I. A. Wahbi, and Y. Hassan, Farmaco, 48, 1137-1151 (1993). 64. X. Meng, Q. Liu, and Q. Jiao, Shipin Gongye Keji, (6), 77-79 (1997). 65. I.

Download PDF sample

Rated 4.19 of 5 – based on 28 votes